{'52WeekChange': 0.063424945,
 'SandP52WeekChange': 0.0644362,
 'address1': '45 Wiggins Avenue',
 'algorithm': None,
 'annualHoldingsTurnover': None,
 'annualReportExpenseRatio': None,
 'ask': 31,
 'askSize': 800,
 'averageDailyVolume10Day': 149187,
 'averageVolume': 137233,
 'averageVolume10days': 149187,
 'beta': None,
 'beta3Year': None,
 'bid': 25,
 'bidSize': 1200,
 'bookValue': 7.141,
 'category': None,
 'circulatingSupply': None,
 'city': 'Bedford',
 'companyOfficers': [],
 'country': 'United States',
 'currency': 'USD',
 'dateShortInterest': 1593475200,
 'dayHigh': 29.06,
 'dayLow': 25.0001,
 'dividendRate': None,
 'dividendYield': None,
 'earningsQuarterlyGrowth': None,
 'enterpriseToEbitda': -15.296,
 'enterpriseToRevenue': None,
 'enterpriseValue': 619914112,
 'exDividendDate': None,
 'exchange': 'NMS',
 'exchangeTimezoneName': 'America/New_York',
 'exchangeTimezoneShortName': 'EDT',
 'expireDate': None,
 'fiftyDayAverage': 24.422,
 'fiftyTwoWeekHigh': 39.04,
 'fiftyTwoWeekLow': 15.82,
 'fiveYearAverageReturn': None,
 'fiveYearAvgDividendYield': None,
 'floatShares': 8290383,
 'forwardEps': -1.53,
 'forwardPE': -16.437908,
 'fromCurrency': None,
 'fullTimeEmployees': 56,
 'fundFamily': None,
 'fundInceptionDate': None,
 'gmtOffSetMilliseconds': '-14400000',
 'heldPercentInsiders': 0.01282,
 'heldPercentInstitutions': 1.03553,
 'industry': 'Biotechnology',
 'isEsgPopulated': False,
 'lastCapGain': None,
 'lastDividendValue': None,
 'lastFiscalYearEnd': 1577750400,
 'lastMarket': None,
 'lastSplitDate': None,
 'lastSplitFactor': None,
 'legalType': None,
 'logo_url': 'https://logo.clearbit.com/stoketherapeutics.com',
 'longBusinessSummary': 'Stoke Therapeutics, Inc., an early-stage '
                        'biopharmaceutical company, develops novel antisense '
                        'oligonucleotide medicines to treat the underlying '
                        'causes of severe genetic diseases. Its lead product '
                        'candidate, STK-001 used to treat Dravet syndrome, a '
                        'severe and progressive genetic epilepsy. Stoke '
                        'Therapeutics, Inc. has a partnership with Invitae '
                        'Corporation to offer genetic testing. The company was '
                        'formerly known as ASOthera Pharmaceuticals, Inc. and '
                        'changed its name to Stoke Therapeutics, Inc. in May '
                        '2016. Stoke Therapeutics, Inc. was founded in 2014 '
                        'and is headquartered in Bedford, Massachusetts.',
 'longName': 'Stoke Therapeutics, Inc.',
 'market': 'us_market',
 'marketCap': 835415104,
 'maxAge': 1,
 'maxSupply': None,
 'messageBoardId': 'finmb_251758622',
 'morningStarOverallRating': None,
 'morningStarRiskRating': None,
 'mostRecentQuarter': 1585612800,
 'navPrice': None,
 'netIncomeToCommon': -37622000,
 'nextFiscalYearEnd': 1640908800,
 'open': 29.03,
 'openInterest': None,
 'payoutRatio': 0,
 'pegRatio': None,
 'phone': '781-430-8200',
 'previousClose': 29.27,
 'priceHint': 2,
 'priceToBook': 3.5219157,
 'priceToSalesTrailing12Months': None,
 'profitMargins': 0,
 'quoteType': 'EQUITY',
 'regularMarketDayHigh': 29.06,
 'regularMarketDayLow': 25.0001,
 'regularMarketOpen': 29.03,
 'regularMarketPreviousClose': 29.27,
 'regularMarketPrice': 29.03,
 'regularMarketVolume': 212362,
 'revenueQuarterlyGrowth': None,
 'sector': 'Healthcare',
 'sharesOutstanding': 33217300,
 'sharesPercentSharesOut': 0.1076,
 'sharesShort': 3549304,
 'sharesShortPreviousMonthDate': 1590710400,
 'sharesShortPriorMonth': 3050721,
 'shortName': 'Stoke Therapeutics, Inc.',
 'shortPercentOfFloat': 0.29299998,
 'shortRatio': 19.04,
 'startDate': None,
 'state': 'MA',
 'strikePrice': None,
 'symbol': 'STOK',
 'threeYearAverageReturn': None,
 'toCurrency': None,
 'totalAssets': None,
 'tradeable': False,
 'trailingAnnualDividendRate': None,
 'trailingAnnualDividendYield': None,
 'trailingEps': -2.662,
 'twoHundredDayAverage': 24.277662,
 'volume': 212362,
 'volume24Hr': None,
 'volumeAllCurrencies': None,
 'website': 'http://www.stoketherapeutics.com',
 'yield': None,
 'ytdReturn': None,
 'zip': '01730'}